20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T77652 | SARS-CoV-2 3CLpro-IN-20 | Antiviral , SARS-CoV | |
SARS-CoV-2 3CLpro-IN-20 is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 0.43 μM,).SARS-CoV-2 3CLpro-IN-20 has potential antiviral activity. | |||
T79659 | SARS-CoV-2 3CLpro-IN-16 | SARS-CoV | |
SARS-CoV-2 3CLpro-IN-16 is a covalent SARS-CoV-2 3CLpro inhibitor that inhibits 3CLpro activity and achieves its inhibitory effect by forming a covalent bond with Cys145. | |||
T61774 | SARS 3CLpro-IN-1 | ||
SARS 3CLpro-IN-1 (Compound 3b) is a stereo-specific SARS 3CL protease inhibitor that belongs to the octahydroisochromene scaffold. It demonstrates inhibition against the P1 site imidazole, with an IC50 value of 95 μM [1]... | |||
T9351 | Nirmatrelvir | SARS-CoV | |
PF-07321332 is a potent and orally active inhibitor of SARS-CoV 3C-like protease (3CLPRO) . | |||
T79660 | SARS-CoV-2 3CLpro-IN-17 | SARS-CoV | |
Compound 3h, also known as SARS-CoV-2 3CLpro-IN-17, is a selective inhibitor of the SARS-CoV-2 3CL protease, demonstrating an IC50 of 0.322 μM [1]. | |||
T63385 | SARS-CoV-2 3CLpro-IN-2 | ||
SARS-CoV-2 3CLpro-IN-2 is a potent inhibitor of the 3CL protease pair and has shown research potential for SARS-CoV-2 disease. | |||
T79376 | SARS-CoV-2 3CLpro-IN-19 | SARS-CoV | |
SARS-CoV-2 3CLpro-IN-19 (Compound C5a), a non-covalent, non-peptide inhibitor of the SARS-CoV-2 3CLpro enzyme, exhibits potent in vitro activity with an IC50 of 0.7 μM. It demonstrates broad-spectrum efficacy against inf... | |||
T72370 | SARS-CoV-2 3CLpro-IN-6 | ||
SARS-CoV-2 3CLpro-IN-6 is a reversible covalent inhibitor targeting the SARS-CoV-2 3CL protease, demonstrating potent inhibitory activity with an IC50 of 4.9 μM. It is utilized in the research of coronavirus disease 2019... | |||
T79661 | SARS-CoV-2 3CLpro-IN-18 | SARS-CoV | |
SARS-CoV-2 3CLpro-IN-18 (Compound 3C) is a covalent inhibitor of SARS-CoV-2 3CLpro with an IC50 of 0.478 μM. It demonstrates inhibition of SARS-CoV-2 in Vero E6 cells, with an EC50 of 2.499 μM, and exhibits low cytotoxic... | |||
T79676 | SARS-CoV-2 3CLpro-IN-21 | Virus Protease | |
SARS-CoV-2 3CLpro-IN-21 (Compound D6) is an irreversible, covalent inhibitor of SARS-CoV-2 3CL pro, demonstrating potent inhibition with an IC50 of 0.03 μM. Additionally, it exhibits inhibitory activity against SARS-CoV-... | |||
T72313 | SARS-CoV-2 3CLpro-IN-11 | ||
SARS-CoV-2 3CLpro-IN-11(11d) is a broad-spectrum antiviral compound that effectively inhibits the SARS-CoV-2 3CL protease, achieving an IC50 of 140 nM. Additionally, it exhibits inhibitory activity against SARS-CoV-1 and... | |||
T62734 | SARS-CoV-2 3CLpro-IN-4 | ||
SARS-CoV-2 3CLpro-IN-4 (Compound 5g) is a multifunctional inhibitor of SARS CoV-2 3CLpro, exhibiting antiviral, antibacterial, and antifungal activities. | |||
T63679 | SARS-CoV-2 3CLpro-IN-3 | ||
SARS-CoV-2 3CLpro-IN-3 is a SARS CoV-2 3CLpro inhibitor that exhibits antiviral, antibacterial, and antifungal effects. | |||
T72364 | SARS-CoV-2 3CLpro-IN-5 | SARS-CoV | |
SARS-CoV-2 3CLpro-IN-5 is a covalent inhibitor targeting the 3C-like protease (3CLpro), exhibiting potent inhibitory activity with an IC50 of 3.8 nM and demonstrating 9.0% oral bioavailability (BA). It is utilized in the... | |||
T79462 | SARS-CoV-2 3CLpro-IN-14 | SARS-CoV | |
SARS-CoV-2 3CLpro-IN-14 (compound 11j) is an orally active inhibitor of SARS-CoV-2 3CLpro, demonstrating potent anti-SARS-CoV-2 properties with an EC50 of 0.18 μM and exhibits minimal cytotoxicity, having a CC50 greater ... | |||
T80657 | SARS-CoV-2 3CLpro-IN-15 | Virus Protease | |
SARS-CoV-2 3CLpro-IN-15 (compound a), a beta-nitrostyrene derivative, acts as an inhibitor of the SARS-CoV-2 3CL protease (3CLpro), effectively inhibiting viral replication and transcription. It is instrumental in the id... | |||
T72371 | SARS-CoV-2 3CLpro-IN-7 | ||
SARS-CoV-2 3CLpro-IN-7 is a reversible covalent inhibitor of the SARS-CoV-2 3CL protease, exhibiting an inhibitory concentration (IC50) value of 1.4 µM. | |||
T63537 | SARS-CoV-2 3CLpro-IN-1 | ||
SARS-CoV-2 3CLpro-IN-1 (Compound 14c) is a highly potent inhibitor specifically designed to target and inhibit the activity of SARS-CoV-2 3CL pro, which is a cysteine-protease found in the main coronaviruses. This partic... | |||
T74807 | SARS-CoV-2 3CLpro-IN-13 | ||
SARS-CoV-2 3CLpro-IN-13 is a potent inhibitor of the SARS-CoV-2 3CL protease, demonstrating significant anti-coronavirus activity with an IC50 value of 21 nM [1]. | |||
T72312 | SARS-CoV-2 3CLpro-IN-10 | ||
SARS-CoV-2 3CLpro-IN-10(5d) is a potent inhibitor of the SARS-CoV-2 3CL protease, exhibiting an IC50 value of 190 nM, and demonstrates varied efficiency against other coronaviruses with IC50 values of 790 nM for SARS-CoV... |